Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer
Full Transcript: Pulsenmore H1 2026 Earnings Call
Pulsenmore Expands Its Fertility Platform into the UK
Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring
Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026
Pulsenmore H1 EPS $(1.83), Sales $2.042M
Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026
Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring
Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program
Pulsenmore Shares Soar After Joining Israel’s Healthcare AI Sandbox Programme (PLSM)
Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead a $1 Million AI Development Project
Pulsenmore Selected To Participate In Israel's Healthcare AI Regulatory Sandbox Program; Co. To Receive Funding From IIA As Part Of Project
Why Is Pulsenmore Stock Falling On Friday?
Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor
Why Did PLSM Stock Surge More Than 200% Today?
Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States
Why Is Pulsenmore Stock Soaring Wednesday?
Pulsenmore Partners With Ouma Health, A Provider Of Virtual Maternity Care Solutions; Deals Terms Were Not Disclosed
Pulsenmore FY EPS $(0.77), Sales $12.547M
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.